Dermatology
Dermatology
Advertisement
Rebecca AraujoPublic Health | April 24, 2024
The majority of children and adolescents with chronic skin conditions reported experiencing stigma.
Read More
Cailin ConnerChronic Spontaneous Urticaria | April 23, 2024
C5a, IL-9, and apo A-IV were identified as potential biomarkers for predicting CSU severity.
Cailin ConnerChronic Spontaneous Urticaria | April 23, 2024
Autologous serum skin test positivity was associated with a delayed response to omalizumab treatment in patients with CSU.
Cailin ConnerChronic Spontaneous Urticaria | April 22, 2024
A study highlighted the underutilization of patient-reported outcome measures in the management of AD and CU.
Cailin ConnerChronic Spontaneous Urticaria | April 22, 2024
Disparities in access to omalizumab for patients with CSU significantly impact treatment patterns and health outcomes.
Cailin ConnerChronic Spontaneous Urticaria | April 22, 2024
CSU negatively affects quality of life, and patients with CSU are more likely to have worse sleep.
Lou PorteroEczema | March 25, 2024
Children whose eczema began before 4 months had more food allergies than those whose eczema began after 12 months.
Tamara ThomasEczema | March 19, 2024
Children with atopic dermatitis (eczema) may be at increased risk for developing allergic contact dermatitis.
Cailin ConnerChronic Spontaneous Urticaria | March 15, 2024
Two phase 3 trials of dupilumab in chronic spontaneous urticaria demonstrated significant improvement in urticaria activity.
Cailin ConnerChronic Spontaneous Urticaria | March 15, 2024
According to a meta-analysis, there are statistically significant higher mean total IgE levels in responders to omalizumab th
Cailin ConnerChronic Spontaneous Urticaria | March 15, 2024
A twofold increase in dosage of desloratadine to 10 mg once daily significantly improves disease severity of CSU.
Cailin ConnerChronic Spontaneous Urticaria | March 15, 2024
The SDown-CSU study emphasized a global need for clear guidance on stepping down chronic spontaneous urticaria treatment.
Cailin ConnerChronic Spontaneous Urticaria | March 14, 2024
A prospective study found that omalizumab and dupilumab effectively managed moderate-to-severe allergic diseases.
Tamara ThomasDermatology | March 7, 2024
The impact of physiologic changes in pregnancy on rosacea severity is unclear.
Cailin ConnerChronic Spontaneous Urticaria | February 27, 2024
The cross-sectional study found that CSU exhibits similar prevalence in pediatric and adult patients.
Cailin ConnerChronic Spontaneous Urticaria | February 26, 2024
A global survey of allergists and immunologists revealed that 82% favored prescribing omalizumab for CSU.
Cailin ConnerChronic Spontaneous Urticaria | February 23, 2024
A new app developed by urticaria specialists offers a user-friendly platform that allows patients with CSU to track symptoms.
Cailin ConnerChronic Spontaneous Urticaria | February 22, 2024
A study found that serum amyloid A-1 (SAA-1) levels positively correlate with disease activity.
Tamara ThomasChronic Spontaneous Urticaria | February 8, 2024
Patients in the CSU group had hypothyroidism and malignancies, the majority having active disease.
Tamara ThomasEczema | March 16, 2024
"Atopic Dermatitis (AD) can be extremely hard to live with."
Advertisement
Advertisement
Advertisement
Latest News

April 26, 2024